COSMO Pharmaceuticals Forecast, price target & analysts
COSMO Pharmaceuticals Target price 2026 - Analyst rating & recommendation
COSMO Pharmaceuticals Classifications & Recommendation
COSMO Pharmaceuticals Price Target
| Target Price | CHF125.65 |
| Price | CHF55.90 |
| Potential |
124.77%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target COSMO Pharmaceuticals 2027 .
The average COSMO Pharmaceuticals target price is CHF125.65.
This is
124.77%
register free of charge
CHF179.96
221.92%
register free of charge
CHF86.55
54.83%
register free of charge
|
|
| A rating was issued by 11 analysts: 10 Analysts recommend COSMO Pharmaceuticals to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the COSMO Pharmaceuticals stock has an average upside potential 2027 of
124.77%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million CHF | 98.30 | 102.33 |
| 60.95% | 4.10% | |
| EBITDA Margin | -1.10% | 11.40% |
| 101.94% | 1,137.61% |
7 Analysts have issued a sales forecast COSMO Pharmaceuticals 2026 . The average COSMO Pharmaceuticals sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an COSMO Pharmaceuticals EBITDA forecast 2026. The average COSMO Pharmaceuticals EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share CHF | -0.21 | 0.06 |
| 102.73% | 128.57% | |
| P/E | 860.47 | |
| EV/Sales | 8.34 |
6 Analysts have issued a COSMO Pharmaceuticals forecast for earnings per share. The average COSMO Pharmaceuticals EPS is
This results in the following potential growth metrics and future valuations:
COSMO Pharmaceuticals...
Current COSMO Pharmaceuticals Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| ODDO BHF |
Locked
➜
Locked
|
Locked | Sep 21 2026 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Aug 25 2026 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Jul 24 2026 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Jul 13 2026 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Jun 22 2026 |
| H.C. WAINWRIGHT & CO., LLC |
Locked
➜
Locked
|
Locked | Apr 20 2026 |
| H.C. WAINWRIGHT & CO., LLC |
Locked
➜
Locked
|
Locked | Apr 19 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Sep 21 2026 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Aug 25 2026 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Jul 24 2026 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Jul 13 2026 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Jun 22 2026 |
|
Locked
H.C. WAINWRIGHT & CO., LLC:
Locked
➜
Locked
|
Apr 20 2026 |
|
Locked
H.C. WAINWRIGHT & CO., LLC:
Locked
➜
Locked
|
Apr 19 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
